Berlin Heals

Executive Summary

Berlin Heals is a Swiss medical device company dedicated to developing innovative implantable devices for the treatment of heart failure and cardiovascular diseases. Founded in 2016 and headquartered in Zurich, the company leverages proprietary technology to address significant unmet needs in chronic cardiac conditions. Berlin Heals focuses on minimally invasive solutions that could improve patient outcomes and quality of life. While the company is still in early stages, with no disclosed funding rounds or commercial products, its approach targets a large and growing market. The company's progress remains under the radar, but its technology could position it as a key player in the cardiac device space if clinical validation is achieved.

Upcoming Catalysts (preview)

• Q4 2026Publication of preclinical or early clinical data60% success
• TBDCE mark application or first regulatory submission30% success